dockets: FDA-2017-P-7033

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-2017-P-7033 FDA Requests that the FDA determine that the drug product, Oxcarbazepine Oral Tablet 450 mg (dual scored) is suitable for consideration in an Abbreviated New Drug Application Nonrulemaking 2023-04-19T16:15:12Z 0b00006482d843d8   CLOSED     ["Citizen Petition", "CDER-OGD", "Jubilant Generics Limited", "in an Abbreviated New Drug Application", "determinethat the drug product", "Oxcarbazepine Oral Tablet 450 mg", "(dual scored) is suitable for consideration", "CLOSED"] CDER-OGD Requests that the FDA determine that the drug product, Oxcarbazepine Oral Tablet 450 mg (dual scored) is suitable for consideration in an Abbreviated New Drug Application     {"displayProperties": [{"name": "abstract", "label": "General Information", "tooltip": "Describes an agency's specific regulatory action; equivalents: Abstract, Description, Docket Subject, Related To, Summary."}, {"name": "generic", "label": "Docket Item Code", "tooltip": "An agency specific code that identifies the type of document that established the docket (regulatory action)."}, {"name": "program", "label": "Center", "tooltip": "The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code, Location."}, {"name": "field2", "label": "Docket Status", "tooltip": "Used to Identity that a Docket's Status is Open or Closed"}, {"name": "shortTitle", "label": "Short Title", "tooltip": "A combination of letters and or numbers assigned to an agency's regulatory action for purposes of brevity."}], "keywords": ["Citizen Petition", "CDER-OGD", "Jubilant Generics Limited", "in an Abbreviated New Drug Application", "determinethat the drug product", "Oxcarbazepine Oral Tablet 450 mg", "(dual scored) is suitable for consideration", "CLOSED"], "modifyDate": "2023-04-19T16:15:12Z", "dkAbstract": "CLOSED", "agencyId": "FDA", "program": "CDER-OGD", "shortTitle": "Requests that the FDA determine that the drug product, Oxcarbazepine Oral Tablet 450 mg (dual scored) is suitable for consideration in an Abbreviated New Drug Application", "subType2": null, "title": "Requests that the FDA determine that the drug product, Oxcarbazepine Oral Tablet 450 mg (dual scored) is suitable for consideration in an Abbreviated New Drug Application", "generic": "P", "field1": null, "docketType": "Nonrulemaking", "petitionNbr": null, "rin": null, "organization": null, "legacyId": null, "subType": null, "category": null, "field2": "CLOSED", "effectiveDate": null, "objectId": "0b00006482d843d8"} single_get

Links from other tables